ASN
PRVB

Advisory Services Network’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Advisory Services Network’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,212
Closed -$37K – 3158
2020
Q4 		$37K Sell
2,212
-330
-13% -$4.95K ﹤0.01% 1842
2020
Q3 		$33K Buy
+2,542
New +$32.1K ﹤0.01% 1799

Other funds holding PRVB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Advisory Services Network's PRVB Position: Q1 2021 in Review

Advisory Services Network sold out of Provention Bio, Inc. Common Stock (PRVB) in Q1 2021, closing a stake of 2,212 shares — an estimated $37K sold.

Advisory Services Network first reported a position in PRVB in Q3 2020 and held it in 2 quarters. The position peaked at $37K in Q4 2020. 120 funds tracked by Wall St. Rank hold PRVB as of Q1 2021.

  • Advisory Services Network reported no remaining Provention Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Advisory Services Network sold 2,212 Provention Bio, Inc. Common Stock shares in Q1 2021, an estimated $37K.
  • Advisory Services Network first reported a position in Provention Bio, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Advisory Services Network's Provention Bio, Inc. Common Stock position peaked at $37K in Q4 2020.
  • 120 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.